Psykiatrisk Center Kobenhavn

At Psykiatrisk Center Kobenhavn, clinical trials in Psychiatry and Psychology focus on mental disorders such as non-affective psychosis and schizophrenia, with additional attention to cannabis use. The research is aimed at testing new treatment options and better understanding how symptoms and substance use may interact.

• Evaluating cannabidiol (CBD) as a potential treatment for psychosis
• Studying the relationship between psychotic symptoms and lifetime cannabis use
• Exploring ways to improve care for people living with persistent psychotic disorders

This area of research supports more effective and patient-centered approaches for complex psychiatric conditions.

Clinical research at the site also addresses bipolar disorder, type II, within the broader field of mental disorders. These studies are designed to compare treatments that may help stabilize mood, reduce relapse, and improve everyday functioning for people living with bipolar illness.

• Comparing lithium and lamotrigine for mood stabilization
• Assessing whether treatment effects are more helpful for manic, depressive, or relapse-prevention needs
• Focusing on longer-term outcomes that matter to patients with bipolar disorder

The work reflects a practical effort to identify treatments that better match the needs of people with BDII.

Another important research area involves psychiatric disorders with comorbid chronic insomnia. Trials in this area aim to improve sleep and overall mental health by evaluating treatments that can be added to usual care.

• Testing melatonin and low-dose quetiapine against placebo for insomnia symptoms
• Studying sleep treatment in adolescents and adults with psychiatric illness
• Looking for safer and more effective options to support restorative sleep

This line of research may help clinicians better manage sleep problems that often complicate psychiatric treatment.

The Akutafdelingen at Psykiatrisk Center København is also involved in studies on acute agitation in emergency psychiatry. These trials focus on rapid calming strategies and improving the quality and safety of care during urgent psychiatric situations.

• Comparing medicines used for rapid tranquillization in acute agitation
• Evaluating practical approaches for emergency psychiatric care
• Aiming to support safer and more effective short-term symptom control

This research area is especially relevant for patients and staff working in fast-paced crisis settings.

Trials at the site also explore alcohol use disorder within Psychiatry and Psychology, with a focus on whether novel approaches can reduce heavy drinking and support recovery. The goal is to assess treatment effects in a controlled clinical setting.

• Studying psilocybin as a possible aid for reducing alcohol intake
• Measuring changes in drinking behavior over time
• Investigating new options for people who have not responded well to standard care

This research reflects growing interest in innovative therapies for substance-related disorders.

The site is also studying the metabolic effects of treatment in people with schizophrenia, especially those with prediabetes or diabetes. These trials aim to better understand how to protect physical health while treating serious mental illness.

• Comparing approaches to improve metabolic state during antipsychotic treatment
• Focusing on patients who have started clozapine or olanzapine
• Seeking ways to reduce long-term health risks linked to psychiatric treatment

This work connects mental health care with broader medical monitoring and prevention.